141 related articles for article (PubMed ID: 16114542)
1. [Effects of rosiglitazone on serum leptin and insulin resistance in patients with Type 2 diabetes].
Wu J; Lei MX; Chen HL; Sun ZX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):623-6. PubMed ID: 16114542
[TBL] [Abstract][Full Text] [Related]
2. [Serum leptin and insulin resistance in obesity and effects of sibutramine on them].
Wu J; Lei MX; Chen HL
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):605-7. PubMed ID: 15804071
[TBL] [Abstract][Full Text] [Related]
3. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
Liu HL; Lin YG; Wu J; Sun H; Gong ZC; Hu PC; Yin JY; Zhang W; Wang D; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2008 Jul; 64(7):663-71. PubMed ID: 18438653
[TBL] [Abstract][Full Text] [Related]
4. [Effects of rosiglitazone on endothelium-dependent vasodilation in patients with Type 2 diabetes].
Wu J; Lei MX; Liu L; Huang YJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):570-4. PubMed ID: 16951521
[TBL] [Abstract][Full Text] [Related]
5. [Effect of acupuncture on serum leptin level in patients with type II diabetes mellitus].
Cai H; Zhao LJ; Zhao ZM; Guo JH; Yuan AH
Zhen Ci Yan Jiu; 2011 Aug; 36(4):288-91. PubMed ID: 21942183
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus.
Kim HJ; Kim SK; Shim WS; Lee JH; Hur KY; Kang ES; Ahn CW; Lim SK; Lee HC; Cha BS
Diabetes Res Clin Pract; 2008 Jul; 81(1):42-9. PubMed ID: 18394743
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
[TBL] [Abstract][Full Text] [Related]
8. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
9. [Effect of rosiglitazone on level of serum TNF-alpha and its relation with insulin resistance in type 2 diabetes mellitus].
Chen HL; Wu J; Liao L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):190-1, 211. PubMed ID: 16145910
[TBL] [Abstract][Full Text] [Related]
10. Circulating ApoJ is closely associated with insulin resistance in human subjects.
Seo JA; Kang MC; Ciaraldi TP; Kim SS; Park KS; Choe C; Hwang WM; Lim DM; Farr O; Mantzoros C; Henry RR; Kim YB
Metabolism; 2018 Jan; 78():155-166. PubMed ID: 28986164
[TBL] [Abstract][Full Text] [Related]
11. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
13. [Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes].
Zhu HL; Yu RM; Huang XZ; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1050-1. PubMed ID: 18583261
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium].
Liu T; Fang Z; Yang D; Liu Q
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):436-9. PubMed ID: 22932110
[TBL] [Abstract][Full Text] [Related]
15. Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus.
Maruyama S; Yanagisawa K; Kanamuro R; Teno S; Iwamoto Y
Diabetes Res Clin Pract; 2001 Sep; 53(3):161-4. PubMed ID: 11483231
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD.
Lin SH; Lin YF; Kuo SW; Hsu YJ; Hung YJ
Am J Kidney Dis; 2003 Oct; 42(4):774-80. PubMed ID: 14520628
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients.
Taniguchi A; Fukushima M; Ohya M; Nakai Y; Yoshii S; Nagasaka S; Matsumoto K; Taki Y; Kuroe A; Nishimura F; Seino Y
Metabolism; 2006 Feb; 55(2):258-62. PubMed ID: 16423635
[TBL] [Abstract][Full Text] [Related]
18. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
19. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
Abdin AA; Baalash AA; Hamooda HE
J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy observation of acupuncture and tapping therapy in the treatment of type 2 diabetes of yin deficiency pattern combined with stasis in the patients].
Wang YD; Liu ZC; Xu B
Zhongguo Zhen Jiu; 2014 Aug; 34(8):731-5. PubMed ID: 25335242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
